论文信息 - Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy - 字舞流文

Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy

Chongqing Tan | Qiao Liu | X. Luo | Liubao Peng | Lidan Yi | X. Wan | Xiaohui Zeng | Sini Li | Shuxia Qin | Liting Wang | Ye Peng | Xia Luo | X. Luo | Ye Peng | L. Peng